NEWS

NEWS TYPE
RELEASE YEAR

RESEARCH

[Publication] Gut microbial carbohydrate metabolism contributes to insulin resistance

October 3, 2023

Title

Gut microbial carbohydrate metabolism contributes to insulin resistance

Authors

Tadashi Takeuchi [1]; Tetsuya Kubota [1],[2],[3],[4],[5]; Yumiko Nakanishi [1],[2]; Hiroshi Tsugawa [6],[7],[8],[9]; Wataru Suda [10]; Andrew Tae-Jun Kwon [11]; Junshi Yazaki [12]; Kazutaka Ikeda [7],[13]; Shino Nemoto [1]; Yoshiki Mochizuki [12]; Toshimori Kitami [14]; Katsuyuki Yugi [15],[16],[17]; Yoshiko Mizuno [18],[19]; Nobutake Yamamichi [20]; Tsutomu Yamazaki [21]; Iseki Takamoto [3],[22]; Naoto Kubota [3]; Takashi Kadowaki [3],[23]; Erik Arner [11]; Piero Carninci [24],[25]; Osamu Ohara [12],[13]; Makoto Arita [7],[8],[26],[27]; Masahira Hattori [10]; Shigeo Koyasu [28] & Hiroshi Ohno [1],[2],[8]

DOI https://doi.org/10.1038/s41586-023-06466-x
Journal Nature
Vol/Num/Page volume 621, pages 389-395
Published Date 30 August 2023

Affiliations:
[1] Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.

[2] Intestinal Microbiota Project, Kanagawa Institute of Industrial Science and Technology, Kawasaki, Japan.
[3] Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
[4] Division of Diabetes and Metabolism, The Institute for Medical Science Asahi Life Foundation, Tokyo, Japan.
[5] Department of Clinical Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Tokyo, Japan.
[6] Metabolome Informatics Research Team, RIKEN Center for Sustainable Resource Science (CSRS), Yokohama, Japan.
[7] Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
[8] Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
[9] Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan.
[10] Laboratory for Microbiome Sciences, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
[11] Laboratory for Applied Regulatory Genomics Network Analysis, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
[12] Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
[13] Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan.
[14] Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
[15] Laboratory for Integrated Cellular Systems, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
[16] Institute for Advanced Biosciences, Keio University, Fujisawa, Japan. 
[17] Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
[18] Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
[19] Development Bank of Japan, Tokyo, Japan.
[20] Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan.
[21] International University of Health and Welfare, Tokyo, Japan.
[22] Department of Metabolism and Endocrinology, Tokyo Medical University Ibaraki Medical Center, Ami Town, Japan.
[23] Toranomon Hospital, Tokyo, Japan.
[24] Laboratory for Transcriptome Technology, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
[25] Fondazione Human Technopole, Milan, Italy.
[26] Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
[27] Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q), Keio University, Tokyo, Japan.
[28] Laboratory for Immune Cell Systems, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.

 

More Bio2Q News

ANNOUNCEMENT
2026.11.20

【Nov. 25 Seminar】 WPI-Bio2Q Open Seminar: Xu Zhang, PhD(for Keio Members)

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty, students, and staff of Keio University.   Date and Time  Wednesday, November 25, 2026, 11:00-11:40 Format Zoom (Online only) Title Senescent Cell–Derived Factors Suppress Innate Antiviral Immunity During Aging Speaker Xu Zha...

EVENT
2026.11.17

【Event Report】Bio2Q Participates in the 15th WPI Science Symposium, Engaging wit...

On Saturday, November 14, 2026, the 15th WPI Science Symposium, themed “World Premieres Born from Me! ~Science I Want to Share with Someone~,” was held at the Osaka University Convention Center in Suita, Osaka, hosted by the Osaka University Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe). The event featured a special lecture by Prof. Shimon Sakaguchi (Distinguished University ...

ANNOUNCEMENT
2026.11.16

WPI-Bio2Q now recruiting administrative staff– Deadline: January 11, 2027

WPI-Bio2Q Administrative Office is currently hiring administrative staff. We look forward to receiving applications from candidates with English proficiency who can support international researchers and anticipate to work at Bio2Q Administrative Office. Application Deadline: January 11, 2027 For more details, please refer to the application information at the link below, Application Info...

ANNOUNCEMENT
2026.11.12

New Long-Term Internship Student-Mr. Kevin Deesy

Introducing a new Long-Term Internship Student of Bio2Q We are delighted to welcome Mr. Kevin Deesy as a new Long-Term Research Internship Student of Bio2Q. "Hello Bio2Q team, My name is Kevin Deesy, and I’m currently completing my Master’s in Sustainable Food at the Technical University of Munich (TUM), specializing in molecular biotechnology and microbiology. My research so far has take...

ANNOUNCEMENT
2026.11.10

New Member - Dr. Augustinas Silale

Introducing new member of Bio2Q We are excited to welcome Dr.  Augustinas Silale as a Jr. PI at Bio-2 Core of Bio2Q. "Hello, Bio2Q community! My name is Augustinas (August) Silale. I am from Lithuania. I am delighted to join Bio2Q as a Jr. PI. I read Natural Sciences at the University of Cambridge. My BA project was on fragment-based drug discovery in Prof Sir Tom Blundell’s group, where ...